Identification of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay.
about
Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cellsQuantitative monitoring of mouse lung tumors by magnetic resonance imaging.Visualization and enrichment of live putative cancer stem cell populations following p53 inactivation or Bax deletion using non-toxic fluorescent dyes.ATP-binding cassette transporters modulate both coelenterazine- and D-luciferin-based bioluminescence imagingABCG2-dependent dye exclusion activity and clonal potential in epithelial cells continuously growing for 1 month from limbal explants.Identification of an old antibiotic clofoctol as a novel activator of unfolded protein response pathways and an inhibitor of prostate cancer.The challenge of exploiting ABCG2 in the clinic.A high-content assay strategy for the identification and profiling of ABCG2 modulators in live cells.Influence of bioluminescence imaging dynamics by D-luciferin uptake and efflux mechanisms.Molecular Imaging of Membrane Transporters' Activity in Cancer: a Picture is Worth a Thousand Tubes.Continuing education course #1: non-invasive imaging as a problem-solving tool and translational biomarker strategy in toxicologic pathology.The Drug Excipient Cyclodextrin Interacts With d-Luciferin and Interferes With Bioluminescence ImagingBioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.Human ABCG2: structure, function, and its role in multidrug resistance.E2F1 drives chemotherapeutic drug resistance via ABCG2.In vitro characterization of pralidoxime transport and acetylcholinesterase reactivation across MDCK cells and stem cell-derived human brain microvascular endothelial cells (BC1-hBMECs).Labeling of Luciferase/eGFP-expressing bone marrow-derived stromal cells with fluorescent micron-sized iron oxide particles improves quantitative and qualitative multimodal imaging of cellular grafts in vivo.
P2860
Q28284818-730F0FC1-E7C5-4CEA-A927-B3972F042632Q30560325-C6FDDADC-89DA-41D9-8BB1-AE3D1B1B11E5Q33516216-C4CFCDB0-04D5-482C-BFA1-A41DDD02070AQ33738298-5EF91AFB-5754-4747-935D-6994E5E4C9EAQ33851021-15C68375-AA6A-49FE-99AC-2F7B53B0E811Q34402836-78B51100-5559-42C4-92E1-B13078451014Q34968909-E7CBE62B-CED0-4272-8645-EEBFE5A3D284Q34977187-8546C8DE-256B-4574-A890-7B21D9529FA7Q35096121-B6155A26-45D3-4C25-BC5F-043F6F2BDBAEQ35768413-B687A424-3C46-480F-9081-AC1B88FFAFBFQ36459121-FDBECE0C-1CCD-4D6D-B8CD-59A8CC10F6A3Q37170669-DBD412D2-56D0-4A91-9C5D-739C829C145CQ37409373-B8A8FBBD-BED9-497F-A393-31DFC58FCB9FQ37958162-926CE996-D401-478F-A8B6-7EE0048B0F63Q38003156-902A3BCA-5261-48E8-B0D0-52C455536FCFQ38310909-F65BA444-C65A-4F32-94A4-4F646A137E8BQ38758994-28D52BFE-CBA7-4A1A-8EE3-ABC201550ADCQ50283926-0666E2A9-924A-4848-BEBE-E7F92FDE3474
P2860
Identification of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Identification of inhibitors o ...... g-based high-throughput assay.
@ast
Identification of inhibitors o ...... g-based high-throughput assay.
@en
type
label
Identification of inhibitors o ...... g-based high-throughput assay.
@ast
Identification of inhibitors o ...... g-based high-throughput assay.
@en
prefLabel
Identification of inhibitors o ...... g-based high-throughput assay.
@ast
Identification of inhibitors o ...... g-based high-throughput assay.
@en
P2093
P2860
P1433
P1476
Identification of inhibitors o ...... g-based high-throughput assay.
@en
P2093
John Laterra
Martin G Pomper
Yimao Zhang
Youngjoo Byun
Yunzhao R Ren
P2860
P304
P356
10.1158/0008-5472.CAN-08-4866
P407
P577
2009-06-30T00:00:00Z